Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Liquidia Corporation
.
Show all posts
Showing posts with label
Liquidia Corporation
.
Show all posts
Monday, August 5, 2024
Liquidia Corporation Provides Update on New Drug Application for Yutrepia (treprostinil) inhalation powder
›
Liquidia Corporation (the Company) (NASDAQ: LQDA) announced the U.S. Food and Drug Administration (FDA) providing an update on its review ...
›
Home
View web version
